title: Tamibarotene-induced low-grade reversible intravascular coagulation in a patient with acute promyelocytic leukemia.
authors.forename: Kinya
authors.initials: K
authors.lastname: Ohata
authors.forename: Hirohito
authors.initials: H
authors.lastname: Yamazaki
authors.forename: Hidesaku
authors.initials: H
authors.lastname: Asakura
authors.forename: Shigeru
authors.initials: S
authors.lastname: Shimadoi
authors.forename: Shinji
authors.initials: S
authors.lastname: Nakao
mesh_terms: D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use; D001565:Benzoates / Q000009:adverse effects* / Q000627:therapeutic use*; D006801:Humans; D015473:Leukemia, Promyelocytic, Acute / Q000150:complications* / Q000188:drug therapy*; D008297:Male; D013764:Tetrahydronaphthalenes / Q000009:adverse effects* / Q000627:therapeutic use*; D013927:Thrombosis / Q000139:chemically induced* / Q000517:prevention & control*; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents; D001565:Benzoates; D013764:Tetrahydronaphthalenes; C061133:tamibarotene